Home
overview

SAE Media Group is proud to announce the inaugural Cell and Gene Therapy Conference taking place on the 19th – 20th June 2023.

As part of SAE Media Group’s leading series of drug discovery conferences, this year’s event will not only bring you the key insights you need to develop your cell and gene therapy pipeline by benchmarking against the latest case studies, but it will also give you the opportunity to network with key players throughout the industry.

Are you interested in the latest approaches to therapeutic discovery and the impact of technologies such as AI and CRISPR/CAS-9? Discover novel approaches to delivery and screening with case studies on applications in oncology and rare diseases to demonstrate the enormous potential of cell and gene therapies.

We hope to welcome you to this must attend event in June 2023.


 

  •  EXPLORE the approaches being undertaken to develop cancer and rare disease treatments now to expand your future cell and gene therapy portfolio, with the potential for personalised cancer vaccines, stem-cell treatments for heart failure and haemophilia gene therapies
  • DISCOVER the latest industry developments in the cell and gene therapy field to expand your target range with updates and innovations in: direct CNS-delivery, off-the-shelf screening libraries and personalised neoantigen therapeutics
  • UNCOVER how CRISPR/cas9 has laid the foundation for the next-generation of gene-editing technologies and how challenges in safety, delivery and efficacy have been overcome with real-world-examples from AstraZeneca, CRISPR Therapeutics and Bayer
  • REVIEW approval case studies from a line-up of global industry experts from Astellas, Adaptimmune, Oxford Biomedica and the MHRA to better understand the regulatory pathways.
     

International pharmaceutical experts:
• Cell & Gene Therapy R&D leaders
• Clinical Platform Developers
• Technical experts
• Advanced therapy production

Industry:
• Businesses looking to break into the market
• Established players looking to expand their contacts
• Developers and innovators in cell and gene therapy technology

Conference programme

8:00 Registration & Coffee

9:00 Chairman's Opening Remarks

Roberto Nitsch

Roberto Nitsch, Director - Gene Therapy, Astrazeneca

9:10 Stable Cell lines in Cell and Gene Therapies – developing a platform for GMP lentiviral vector production

Chrysanthi Sitmalidou

Chrysanthi Sitmalidou, Scientist II, Orchard Therapetuics

  •  Importance of lentiviral vectors for cell and gene therapy
  • Orchard’s stable cell line development platform
  • GMP Requirements for LVV Manufacturing with Stable Cell lines
  • 9:50 Addressing patient access challenges for advanced therapeutics

    Diego Ardigo

    Diego Ardigo, ATMP Project and Clinical Program Leader, Chiesi Farmaceutici SpA

  • Autologous versus allogeneic CAR-T cells vs gene therapies
  • Understanding safety and toxicology concerns for ATMPs from patient perspectives
  • Exploring the scalability of cell therapies and the move from R&D to clinic
  •  

    10:30 Morning Coffee

    11:00 A novel, disruptive gene therapy modality- Applicable to DNA

    Nagy Habib

    Nagy Habib, Co-Founder and CMO , Dawn Therapeutics

    11:40 Upgrading on traditional cell therapies with human iPS cell derived ventricular cardiomyocytes stem cell treatments for heart failure

    Takehiko Kaneko

    Takehiko Kaneko, CMO, HeartSeed

  • Comparing the respective challenges and benefits of stem cell treatments compared with established cell therapeutics
  • Strengthening viability and uptake with the use of micro-tissue spheroids transplantation
  • Regenerative medicine, the future of cell and gene therapies?
  • 12:20 Networking Lunch

    13:20 Evaluating the first wave of cell & gene therapies in Europe and the challenges and opportunities going forward

  • Improving the development time for cell and gene therapies with co-designed platforms 
  • Assessing the therapeutic potential and patient benefits for off-the-shelf cell therapies 
  • Evaluating the regulatory pathways for CGTs with considerations from other genomic medicines
  • Reviewing the growth in cell and gene therapy pipelines in a crowded market
  • Roberto Nitsch

    Roberto Nitsch, Director - Gene Therapy, Astrazeneca

    Pelin Candarlioglu

    Pelin Candarlioglu, Chair of Industry Advisory Board , EUROoCS

    Diego Ardigo

    Diego Ardigo, ATMP Project and Clinical Program Leader, Chiesi Farmaceutici SpA

    John Maher

    John Maher, Chief Scientific Officer, Leucid Bio

    14:00 Progressing the therapeutic potential of Mesenchymal-like Adherent Stromal Cells as effective cell therapies

    Lior  Raviv

    Lior Raviv, CTO, Pluristem

  • Applications for stromal cell derived regenerative medicines in mainstream medicine
  • Enhancement of viral transduction efficiency for autologous cell therapy to treat rare diseases
  • Applying Pluristem’s 3D manufacturing platform for cell therapies
  • 14:40 Afternoon Tea

    15:10 CAR T-cell immunotherapy of solid tumours – moving through the generations

    John Maher

    John Maher, Chief Scientific Officer, Leucid Bio

  • Summary of a dose escalation phase 1 clinical trial of panErbB CAR T-cells in patients with head and neck cancer
  • Summary of a novel CAR platform dubbed a lateral CAR
  • Demonstration of enhanced anti-tumour efficacy and functional persistence of lateral CAR T-cells compared to linear comparators
  • 15:50 Applications for the use of stem cells as therapeutic modalities

    Ningshu Liu

    Ningshu Liu, Head of Stem Cells, FosunPharma

  • Understanding the differences between stem cells therapy and cell therapy
  • Maximising therapeutic translation of stem cell research
  • Comparisons between ESCs, iPSCs and adult stem cells for autologous and allogenic therapies
  • Enriching regenerative strategies with stem-cell based therapies
     

     

  • 16:30 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Roberto Nitsch

    Roberto Nitsch, Director - Gene Therapy, Astrazeneca

    9:10 Taking a Recombinant Overlapping Approach

    William Finch

    William Finch, CEO, Oxford Vacmedix

  • Introduction into the recombinant overlapping peptide (ROP) platform
  • Outlining the wide applications of the ROP Technology platform such as cancer and infectious diseases
  • Discussion of advanced therapies in development
  • 9:50 Improving gene therapy efficacy and targeting for rare neuronal disorders

    Giulia Leoni

    Giulia Leoni, Associate Director, Program Management and LeadershipAssociate, Bloomsbury Genetic Therapies

  •  Introduction to the challenges of treating neuronal disorders with gene therapy
  • Understanding how intra-brain gene therapy targeting offers expediated targeting of neuronal pathways
  • Case study information from Bloomsbury Genetic Therapeutics gene therapy pipeline

     

  • 10:30 Morning Coffee

    11:00 Targeting Clonal Neoantigens in Cancer

    Sergio Quezada

    Sergio Quezada, Chief Scientific Officer, Achilles Therapeutics

  • Tumour neoantigens are recognised as important substrates for the recognition of cancerous cells by T cells.
  • However, not all neoantigens are the same and a growing body of evidence underscores a critical role for clonal neoantigens in the response to cancer immunotherapies.
  • At Achilles we have established a state-of-the-art platform (PELEUS) for identification of clonal neoantigens and validation of their immunogenic potential (VELOS). Both PELEUS and VELOS are currently deployed in a first in human trial (ATL001) in which clonal Neoantigen reactive T cells (cNeT) are generated for the treatment of lung cancer and melanoma patients.
  • In this talk we will review the role of clonal neoantigens as targets in cancer immunotherapy as well as the Achilles platform for generation, characterisation and evaluation of cNeT activity in cancer patients.
     
  • 11:40 The next level of CRISPR safety: tackling Cas9 immunogenicity.

    Roberto Nitsch

    Roberto Nitsch, Director - Gene Therapy, Astrazeneca

  • Highlighting how the safety of gene therapies depends on the accuracy of editing detection.
  • Profiling immunogenicity of currently approved gene edited therapies.
  • Case study from AstraZeneca’s CRISPR programme.
  • Optimising the development of animal models for gene-edited therapeutics
     
  • 12:20 Networking Lunch

    13:20 Studying neurodegenerative disorders with stem cell models

    Clare Jones

    Clare Jones, Chief Scientific Officer, Talisman Therapeutics

  • Opening the opportunity for CNS based gene therapies with human stem cell models
  • Accelerating drug target ID and validation with improved biologically relevant models
  • Case Studies of Talisman Therapeutics dementia and neurodegeneration

     

  • 14:00 Overcoming AAV gene therapy issues for with liver models of rare genetic diseases

    Giuseppe Ronzitti

    Giuseppe Ronzitti, Group Leader, Genethon

  • Understanding the liver as a model for rare genetic disorders
  • Overcoming concerns with humoral immunity and the toxicities associated to liver overloading in neuromuscular diseases 
  • Employing IdeS endopeptidase to degrade anti-AAV immunoglobulins
  • 14:40 Afternoon Tea

    15:10 Reviewing a novel gene therapy approach for chronic ocular diseases

    Katie Binley

    Katie Binley, Head of Biology, Ikarovec

  • Outlining the benefits of a multi-target approach
  • Exploring DMO and AMD as gene therapy targets 
  • Key Learnings from pre-clinical studies

     

  • 15:50 Applications of Improved Gene Therapy Methods in Neurologic Disorders

    Thomas Lowe

    Thomas Lowe, Clinical Development Scientist, AviadoBio

  • Assessing the use of gene therapies for both subcortical and cortical degeneration to rescue disease pathology
  • Promoting viral vector delivery through neuro-anatomy led approaches
  • Case studies from AviadoBio’s pre-clinical gene therapy pipeline

     

  • 16:30 Chairman’s Closing Remarks and Close of Day Two

    +

    Scientist II
    Orchard Therapetuics
    Chief Scientific Officer
    Talisman Therapeutics
    ATMP Project and Clinical Program Leader
    Chiesi Farmaceutici SpA
    Associate Director, Program Management and LeadershipAssociate
    Bloomsbury Genetic Therapies
    Group Leader
    Genethon
    Chief Scientific Officer
    Leucid Bio
    Head of Biology
    Ikarovec
    CTO
    Pluristem
    Co-Founder and CMO
    Dawn Therapeutics
    Head of Stem Cells
    FosunPharma
    Chair of Industry Advisory Board
    EUROoCS
    Director - Gene Therapy
    Astrazeneca
    Chief Scientific Officer
    Achilles Therapeutics
    CMO
    HeartSeed
    Clinical Development Scientist
    AviadoBio
    CEO
    Oxford Vacmedix
    CEO
    Oxford Vacmedix

    Exhibitors

    Supporters

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Chair Invitation Letter

    Download

    2023 Brochure

    Download

    Exhibitors


    Cherwell

    Exhibitors
    http://www.cherwell-labs.co.uk.

    Cherwell Laboratories Ltd is a UK manufacturer and supplier of the prepared media Redipor®. The Head Office is in Bicester, Oxfordshire and can boast an excellent transport network, which enables its abilities to work effectively with the Export and Distribution partners as well as all Domestic customers.

    With over 50 years’ experience, Cherwell has become a specialist supplier of ‘cleanroom microbiology solutions’ with products for environmental monitoring and process validation for healthcare, pharmaceutical and industrial applications.

    Because environmental monitoring is a critical element to any manufacturing process, Cherwell focuses on supplying high quality, reliable products, that are supported by expert knowledge. The range within the product portfolio enables professionals to make informed decisions about their cleanroom environment, and sterility processes. Which allows them to select the best suited solutions for them to manage risk associated with a robust contamination control strategy.

    The SAS air environmental sampling range is reliable and robust equipment known to conform to the Annex 1 requirement of 1m³.

    The new ImpactAIR is designed for high-risk graded environments, deploying a monitoring innovation that is called ‘slit to agar’. This system uses a Redipor 9cm plate rather than the standard 14cm. The process provides assurances on potential contamination within the cleanroom environment with a D50 value of 0.53 micron capturing the extremely small-scale particles, complying with the Annex 1 requirements

    We work in partnership within the market and take pride in sharing our knowledge, experience and expertise to ensure that everyone is using our portfolio in the best way possible for their environmental needs and expectations.


    Media Partners


    Genomeweb L L C

    Supporters
    http://www.genomeweb.com

    GenomeWeb LLC is an independent, privately-held online and print publisher based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.

    GenomeWeb’s editorial mission is to serve readers with exclusive, in-depth coverage of the technology, institutions, and scientists that make up the worldwide research enterprise of molecular biology. We operate the largest online news organization focused on advanced research tools in genomics, proteomics, and bioinformatics.

    GenomeWeb readers can be found in major biopharmaceutical companies, top research universities, biomedical institutes, and government laboratories.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Gene Therapy Net

    Supporters
    http://www.genetherapynet.com

    Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    On Drug Delivery

    Supporters
    http://www.ondrugdelivery.com/subscribe

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.


    World Pharma News

    Supporters
    http://www.worldpharmanews.com/



    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out